(SYM) Symbotic - Overview
Stock: Automation, Robotics, Warehouse
| Risk 5d forecast | |
|---|---|
| Volatility | 82.5% |
| Relative Tail Risk | -10.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.18 |
| Alpha | 74.00 |
| Character TTM | |
|---|---|
| Beta | 2.363 |
| Beta Downside | 1.984 |
| Drawdowns 3y | |
|---|---|
| Max DD | 72.46% |
| CAGR/Max DD | 0.67 |
EPS (Earnings per Share)
Revenue
Description: SYM Symbotic February 05, 2026
Symbotic Inc. (NASDAQ: SYM) is a U.S.-based automation-technology firm that builds robotic systems to move pallets, cases and individual items inside modern warehouses, targeting efficiency gains at the front end of the supply chain. The company is headquartered in Wilmington, Massachusetts, and trades as a common stock within the Industrial Machinery & Supplies & Components sub-industry.
According to Symbotic’s most recent Form 10-K (FY 2025), the firm generated $1.12 billion in revenue, a 28 % year-over-year increase driven primarily by expanded contracts with large retailers-most notably a multi-year automation rollout with Walmart that now covers over 250 of its distribution centers. As of 30 January 2026, market-cap stood near $3.4 billion and the company reported a trailing-12-month (TTM) gross margin of 23.5 %. Key sector drivers that underpin Symbotic’s growth outlook include (1) sustained double-digit e-commerce sales growth (global e-commerce CAGR ≈ 12 % YoY in 2024-2025), (2) persistent labor-shortage pressures prompting retailers to invest in warehouse robotics, and (3) rising total cost-of-ownership advantages of modular automation platforms versus legacy conveyor systems. These macro trends suggest a favorable tailwind, but the company’s valuation remains sensitive to execution risk on large-scale deployments and potential supply-chain constraints for critical components.
For a deeper, data-driven assessment of SYM’s upside potential, you may want to explore ValueRay’s quantitative model.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -10.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA 18.56 > 1.0 |
| NWC/Revenue: 28.22% < 20% (prev 13.66%; Δ 14.56% < -1%) |
| CFO/TA 0.29 > 3% & CFO 853.5m > Net Income -10.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (127.9m) vs 12m ago 20.52% < -2% |
| Gross Margin: 19.21% > 18% (prev 0.15%; Δ 1906 % > 0.5%) |
| Asset Turnover: 101.5% > 50% (prev 111.6%; Δ -10.12% > 0%) |
| Interest Coverage Ratio: -12.58 > 6 (EBITDA TTM -8.90m / Interest Expense TTM 4.44m) |
Altman Z'' -0.82
| A: 0.23 (Total Current Assets 2.46b - Total Current Liabilities 1.78b) / Total Assets 2.99b |
| B: -0.44 (Retained Earnings -1.33b / Total Assets 2.99b) |
| C: -0.02 (EBIT TTM -55.9m / Avg Total Assets 2.35b) |
| D: -0.66 (Book Value of Equity -1.33b / Total Liabilities 2.03b) |
| Altman-Z'' Score: -0.82 = CCC |
Beneish M -3.14
| DSRI: 0.80 (Receivables 357.2m/357.7m, Revenue 2.39b/1.91b) |
| GMI: 0.80 (GM 19.21% / 15.41%) |
| AQI: 1.58 (AQ_t 0.14 / AQ_t-1 0.09) |
| SGI: 1.25 (Revenue 2.39b / 1.91b) |
| TATA: -0.29 (NI -10.9m - CFO 853.5m) / TA 2.99b) |
| Beneish M-Score: -3.14 (Cap -4..+1) = AA |
What is the price of SYM shares?
Over the past week, the price has changed by -2.76%, over one month by -15.30%, over three months by -3.00% and over the past year by +120.65%.
Is SYM a buy, sell or hold?
- StrongBuy: 8
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the SYM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 63.9 | 18.8% |
| Analysts Target Price | 63.9 | 18.8% |
SYM Fundamental Data Overview February 21, 2026
P/S = 13.8776
P/B = 10.4104
P/EG = 10.2043
Revenue TTM = 2.39b USD
EBIT TTM = -55.9m USD
EBITDA TTM = -8.90m USD
Long Term Debt = 43.9m USD (estimated: total debt 52.0m - short term 8.07m)
Short Term Debt = 8.07m USD (from shortTermDebt, last quarter)
Debt = 52.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.77b USD (from netDebt column, last quarter)
Enterprise Value = 31.40b USD (33.17b + Debt 52.0m - CCE 1.82b)
Interest Coverage Ratio = -12.58 (Ebit TTM -55.9m / Interest Expense TTM 4.44m)
EV/FCF = 40.27x (Enterprise Value 31.40b / FCF TTM 779.7m)
FCF Yield = 2.48% (FCF TTM 779.7m / Enterprise Value 31.40b)
FCF Margin = 32.62% (FCF TTM 779.7m / Revenue TTM 2.39b)
Net Margin = -0.45% (Net Income TTM -10.9m / Revenue TTM 2.39b)
Gross Margin = 19.21% ((Revenue TTM 2.39b - Cost of Revenue TTM 1.93b) / Revenue TTM)
Gross Margin QoQ = 20.04% (prev 20.55%)
Tobins Q-Ratio = 10.49 (Enterprise Value 31.40b / Total Assets 2.99b)
Interest Expense / Debt = 219.8% (Interest Expense 114.2m / Debt 52.0m)
Taxrate = 4.40% (615.0k / 14.0m)
NOPAT = -53.4m (EBIT -55.9m * (1 - 4.40%)) [loss with tax shield]
Current Ratio = 1.38 (Total Current Assets 2.46b / Total Current Liabilities 1.78b)
Debt / Equity = 0.08 (Debt 52.0m / totalStockholderEquity, last quarter 663.8m)
Debt / EBITDA = 198.6 (negative EBITDA) (Net Debt -1.77b / EBITDA -8.90m)
Debt / FCF = -2.27 (Net Debt -1.77b / FCF TTM 779.7m)
Total Stockholder Equity = 325.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.46% (Net Income -10.9m / Total Assets 2.99b)
RoE = -3.34% (Net Income TTM -10.9m / Total Stockholder Equity 325.3m)
RoCE = -15.13% (EBIT -55.9m / Capital Employed (Equity 325.3m + L.T.Debt 43.9m))
RoIC = -16.42% (negative operating profit) (NOPAT -53.4m / Invested Capital 325.3m)
WACC = 14.60% (E(33.17b)/V(33.22b) * Re(14.62%) + (debt cost/tax rate unavailable))
Discount Rate = 14.62% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 23.88%
[DCF Debug] Terminal Value 46.82% ; FCFF base≈519.2m ; Y1≈340.8m ; Y5≈155.5m
Fair Price DCF = 25.81 (EV 1.48b - Net Debt -1.77b = Equity 3.25b / Shares 125.8m; r=14.60% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 63.04 | EPS CAGR: 38.94% | SUE: -0.31 | # QB: 0
Revenue Correlation: 91.66 | Revenue CAGR: 65.02% | SUE: 0.29 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.11 | Chg30d=+0.017 | Revisions Net=+4 | Analysts=8
EPS current Year (2026-09-30): EPS=0.50 | Chg30d=+0.036 | Revisions Net=+4 | Growth EPS=-75.0% | Growth Revenue=+23.2%
EPS next Year (2027-09-30): EPS=0.74 | Chg30d=-0.038 | Revisions Net=+2 | Growth EPS=+49.6% | Growth Revenue=+28.9%